Tolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple Sclerosis

(MedPage Today) -- SAN DIEGO -- Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple sclerosis (SPMS), the phase III HERCULES trial showed.
The Bruton's tyrosine kinase (BTK...